Pharmacovigilance (PV) and Drug Safety Software Market to 2027 By Top Leading Players: EXTEDO , ENNOV, Maxapplication, Sparta Systems

The Insight Partners published an Exclusive report on “Pharmacovigilance (PV) and Drug Safety Software Market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 150 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

The global Pharmacovigilance (PV) and drug safety software market is expected to reach US$ 262.02 Mn in 2027 from US$ 151.07 Mn in 2018. The market is estimated to grow with a CAGR of 6.4% from 2019-2027.

Request a sample of this premium report at: https://www.theinsightpartners.com/sample/TIPHC00002557/

Key Players

  • AB Cube
  • United Biosource LLC
  • ArisGlobal LLC
  • Sparta Systems
  • Oracle
  • Sarjen Systems Pvt. Ltd
  • EXTEDO
  • ENNOV
  • Maxapplication
  • Online Business Applications, Inc.

According to the Agency for Healthcare Research and Quality 2018, In the US, 3% to 7% of all hospitalizations are due to adverse drug reactions. ADRs occur from 10% to 20% of admissions; about 10% to 20% of these ADRs are severe. These statistics do not include the number of ADRs that occur in ambulatory and nursing home patients. Although the exact number of ADRs is not specified, ADRs represent a significant public health problem that is, for the most part, preventable. In 2016, 1,238,178 reports related to suspected adverse reactions were collected and managed in EudraVigilance, 339,544 of which originate from the European Economic Area (EEA). European database for adverse drug reaction reports, which Member State and the Agency use for monitoring the safety of authorized medicines on the EU market. EudraVigilance now holds 10.8 million reports referring to 6.7 million cases and therefore is one of the most significant adverse drug reaction databases in the world. Adverse drug reactions (ADRs) reported by a patient or healthcare professional adds to safety monitoring and thus to the safe and effective use of medicines.

Global Pharmacovigilance (PV) and Drug Safety Software Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical white papers, paid databases etc. followed by primary research (interviews) with industry experts/KOLs to gain their insights and views on current scenarios and future scope of the market as well as validating the secondary information, further internal statistical model is used to estimate the market size and forecasts till 2027.

In 2018, this segment held the largest market share in the pharmacovigilance (PV) and drug safety software market, by delivery mode. The segment is also expected to witness growth at a significant rate during the forecast period as on-premise software are therefore best suited for larger pharmaceutical companies with higher budgets.

Pharmacovigilance (PV) and Drug Safety Software Market – Global Analysis to 2027 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.

Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Pharmacovigilance (PV) and Drug Safety Software Industry Insights
Chapter 4. Pharmacovigilance (PV) and Drug Safety Software Market, By Technology
Chapter 5. Pharmacovigilance (PV) and Drug Safety Software Market, By End-user
Chapter 6. Pharmacovigilance (PV) and Drug Safety Software Market, By Region
Chapter 7. Company Profiles

Purchase this premium report at: https://www.theinsightpartners.com/buy/TIPHC00002557/

 

 

 

 

 

 

 

 

 

Comments are closed

News Categories

Featured Press Releases

Log in